DOCSLIB.ORG

上海復星醫藥（集團）股份有限公司 Shanghai Fosun Pharmaceutical

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
上海復星醫藥（集團）股份有限公司 Shanghai Fosun Pharmaceutical Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. 上海復星醫藥（集團）股份有限公司 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 02196) CONNECTED TRANSACTIONS ENTERING INTO THE CAPITAL INCREASE AGREEMENT THE CAPITAL INCREASE AGREEMENT The Board announces that, on 17 September 2020, the Company, Fosun Healthcare and Fosun High Tech entered into the Capital Increase Agreement with Shenzhen Fosun Health and its existing shareholders, Youle Information and Chancheng Hospital, pursuant to which each of the Company, Fosun Healthcare and Fosun High Tech agreed to make capital contribution in the amount of RMB20 million, RMB46 million and RMB34 million, respectively, to increase the registered capital of Shenzhen Fosun Health from RMB20.408 million to RMB 120.408 million. Upon completion of the transactions under the Capital Increase Agreement, the aggregate equity interest in Shenzhen Fosun Health held by the Company will be approximately 63.5% and Shenzhen Fosun Health will remain as a subsidiary of the Company. IMPLICATIONS OF THE HONG KONG LISTING RULES As Youle Information is a company controlled by Mr. Guo Guangchang, the controlling shareholder of the Company, therefore, Youle Information constitutes an associate of Mr. Guo Guangchang and a connected person of the Company under Chapter 14A of the Hong Kong Listing Rules. Further, as Fosun High Tech is the controlling shareholder of the Company, therefore, it also constitutes a connected person of the Company. Accordingly, the transactions contemplated under the Capital Increase Agreement constitute connected transactions of the Company under Chapter 14A of the Hong Kong Listing Rules. Given that the relevant parties to the Capital Increase Agreement are the same connected persons as the relevant parties to Previous Transactions, the transactions contemplated under the Capital Increase Agreement and the Previous Transactions shall be aggregated pursuant to Rule 14A.81 of the Hong Kong Listing Rules. As the percentage ratio applicable to the sum of the transactions contemplated under the Capital Increase Agreement and the Previous Transactions is more than 0.1% but less than 5%, the transactions contemplated under the Capital Increase Agreement are subject to reporting and announcement requirements but are exempted from the independent shareholders’ approval requirement under Chapter 14A of the Hong Kong Listing Rules. 1 A. THE CAPITAL INCREASE CONTRACT The Board announces that, on 17 September 2020, the Company, Fosun Healthcare and Fosun High Tech entered into the Capital Increase Agreement with Shenzhen Fosun Health and its existing shareholders, Youle Information and Chancheng Hospital pursuant to which each of the Company, Fosun Healthcare and Fosun High Tech agreed to make capital contribution in the amount of RMB20 million, RMB46 million and RMB34 million, respectively, to increase the registered capital of Shenzhen Fosun Health from RMB20.408 million to RMB 120.408 million. Upon completion of the transactions under the Capital Increase Agreement, the aggregate equity interest in Shenzhen Fosun Health held by the Company will be approximately 63.5% and Shenzhen Fosun Health will remain as a subsidiary of the Company. The principal terms of the Capital Increase Agreement are summarised below: Date 17 September 2020 Parties (1) The Company; (2) Fosun Healthcare; (3) Fosun High Tech; (4) Youle Information; (5) Chancheng Hospital; and (6) Shenzhen Fosun Health 2 Principal Terms Under the Capital Increase Agreement, the parties agree to the increase in the registered capital of Shenzhen Fosun Health from RMB20.408 million to RMB120.408 million. The parties agreed that the capital contribution to Shenzhen Fosun Health in the aggregate amount of RMB100 million shall be made in the following manner: Capital contribution and subscription Name of party of additional registered capital The Company RMB20 millon Fosun Healthcare RMB46 millon Fosun High Tech RMB34 millon Total RMB100 millon Such investment amount will be financed by the self-raised funds of each of the Company and Fosun Healthcare, respectively. Capital Contribution Arrangement According to the Capital Increase Agreement, each party will pay for the capital contribution according to the following arrangements: (1) Fosun High Tech and the Company shall make one-off payment of their respective capital contribution within five working days from the date of the Capital Increase Agreement; and (2) Fosun Healthcare shall make the first instalment of its capital contribution in the amount of RMB21 million within five working days from the date of the Capital Increase Agreement, and make the remaining part of its capital contribution in the amount of RMB25 million shall be made within half year from the date of the Capital Increase Agreement. 3 Shareholding structure of Shenzhen Fosun Health The shareholding structure of Shenzhen Fosun Health immediately before and after completion of the transactions contemplated under the Capital Increase Agreement is as follows: Unit: RMB million Before completion of the After completion of the Shareholders of transactions under the Capital transactions under the Capital Shenzhen Fosun Health Increase Agreement Increase Agreement Contribution to % of Contribution to % of the registered equity the registered equity capital interest capital interest (approximately) (approximately) The Company 0 0% 20 16.6% Fosun Healthcare 0 0% 46 38.3% Fosun High Tech 0 0% 34 28.2% Youle Information 10 49% 10 8.3% Chancheng Hospital 10.408 51% 10.408 8.6% Total 20.408 100% 120.408 100% Corporate governance Following the completion of the transactions contemplated under the Capital Increase Agreement, the board of directors of Shenzhen Fosun Health shall consist of three directors, of which one director shall be nominated by Fosun High Tech and two directors shall be nominated by the Company; Shenzhen Fosun Health has 1 supervisor to be nominated by the Company. Other terms (1) The Capital Increase Agreement shall be governed by the PRC law. Any dispute shall be resolved by amicable negotiation by parties; otherwise, a legal proceeding shall be brought to the people’s court having jurisdiction at the signing place of the Capital Increase Agreement. (2) The Capital Increase Agreement shall become effective upon affixed with seal by, or signing of, the parties thereto. 4 B. REASONS AND BENEFITS OF THE CAPITAL INCREASE AGREEMENT As an internet medical platform and with staring point of Internet medical consultation, family doctor services and health science content, Shenzhen Fosun Health provides internet medical and family health management services around family users. Entering into the Capital Increase Agreement may be benefit to integrating the medical service resources of the Group, accelerating the development of innovative medical service system, and promoting the internet capability and synergy of business segments of the Group. The proceeds of capital contribution shall be utilised for general working capital of Shenzhen Fosun Health. The Directors (including the independent non-executive Directors) consider that the terms of each of the Capital Increase Agreement are on normal commercial terms, and are fair and reasonable and in the interests of the Company and the Shareholders as a whole. Mr. Chen Qiyu, Mr. Yao Fang, Mr. Xu Xiaoliang, Mr. Gong Ping and Mr. Pan Donghui, being Directors, abstained from voting on the resolution of the Board in respect of the entering into of the Capital Increase Agreemnt, while the remaining 5 Directors (including 4 independent non-executive Directors) participated in the voting and approved unanimously. C. INFORMATION OF SHENZHEN FOSUN HEALTH Shenzhen Fosun Health is a company incorporated in the PRC with limited liability in January 2019. As at the date of this announcement, Youle Information and Chancheng Hospital holds approximately 49% and 51% shareholding in Shenzhen Fosun Health, respectively. Shenzhen Fosun Health is mainly engaged in, among others, health management and health consultation. The net profit (both before and after taxation) of Shenzhen Fosun Health for the financial year ended 31 December 2019 and the 6-month ended 30 June 2020 are as follows: Unit: RMB million For the For the year ended 6-month ended 31 December 30 June 2019 2020 (unaudited) (unaudited) Net profit/(loss) (before taxation) (10.40) (3.38) Net profit/(loss) (after taxation) (10.40) (3.38) As at 30 June 2020, the unaudited total asset value and the unaudited total net asset value of Shenzhen Fosun Health were RMB0.96 million and RMB0.38 million, respectively. 5 D. INFORMATION OF OTHER PARTIES The Group The Group is a leading healthcare group in the PRC and primarily engaged in business segments including pharmaceutical manufacturing and R&D, healthcare services, medical devices and medical diagnosis as well as pharmaceutical distribution and retail. Fosun Healthcare Fosun Healthcare is a company incorporated in PRC with limited liability, and a subsidiary of the Company, which is mainly engaged in the investment in medical and healthcare industry and its related areas,
Load more

Recommended publications
  • ATTACHMENT 1 Barcode:3800584-02 C-570-107 INV - Investigation
    ATTACHMENT 1 Barcode:3800584-02 C-570-107 INV - Investigation - Chinese Producers of Wooden Cabinets and Vanities Company Name Company Information Company Name: A Shipping A Shipping Street Address: Room 1102, No. 288 Building No 4., Wuhua Road, Hongkou City: Shanghai Company Name: AA Cabinetry AA Cabinetry Street Address: Fanzhong Road Minzhong Town City: Zhongshan Company Name: Achiever Import and Export Co., Ltd. Street Address: No. 103 Taihe Road Gaoming Achiever Import And Export Co., City: Foshan Ltd. Country: PRC Phone: 0757-88828138 Company Name: Adornus Cabinetry Street Address: No.1 Man Xing Road Adornus Cabinetry City: Manshan Town, Lingang District Country: PRC Company Name: Aershin Cabinet Street Address: No.88 Xingyuan Avenue City: Rugao Aershin Cabinet Province/State: Jiangsu Country: PRC Phone: 13801858741 Website: http://www.aershin.com/i14470-m28456.htmIS Company Name: Air Sea Transport Street Address: 10F No. 71, Sung Chiang Road Air Sea Transport City: Taipei Country: Taiwan Company Name: All Ways Forwarding (PRe) Co., Ltd. Street Address: No. 268 South Zhongshan Rd. All Ways Forwarding (China) Co., City: Huangpu Ltd. Zip Code: 200010 Country: PRC Company Name: All Ways Logistics International (Asia Pacific) LLC. Street Address: Room 1106, No. 969 South, Zhongshan Road All Ways Logisitcs Asia City: Shanghai Country: PRC Company Name: Allan Street Address: No.188, Fengtai Road City: Hefei Allan Province/State: Anhui Zip Code: 23041 Country: PRC Company Name: Alliance Asia Co Lim Street Address: 2176 Rm100710 F Ho King Ctr No 2 6 Fa Yuen Street Alliance Asia Co Li City: Mongkok Country: PRC Company Name: ALMI Shipping and Logistics Street Address: Room 601 No.
    [Show full text]
  • Foshan Delegation Visit
    Appendix 1 China Visits to Medway 2005 July 2005 – One day visit as a side trip from London Ms Li Xiuping –Deputy Mayor of Foshan Ms. Huang Jun – Deputy Governor – China Development Bank, Guangdong branch Ms. Zhang Qing – Division Director – China Development Bank, Guangdong branch Mr. Cai Weidong – Deputy Division Director – China Development Bank, Guangdong branch Mr. Li Huaduan – Section Member – Foreign Trade & Economic Cooperation, Foshan Bureau Meetings with: Cllr. Chitty / Wendy Mesher / Kathy Wadsworth / Matt Peacock / Simon Curtis SEEDA – Elwyn Nicol / Medway Universities – Jeff Brown The Mayor of Medway Cllr. Ken Webber 2006 September 2006 – Medway Chinese Cultural Festival 2006 (Funded by Medway Dragon and Lion Dance Sports Association) Mr. Luo Jianhua – Vice Chairman – Beijing China Dragon & Lion Dance Association Mr. Yu Hanqiao – General Secretary – Beijing China Dragon & Lion Dance Association Mr. Huang Xizhong – Vice Governor – The People’s Government of Chancheng, Foshan Mr. Liu Feihu – Vice Director Education of The People’s Government of Chancheng, Foshan Mr. Yu Zhicheng – Sports Director – The People’s Government of Chancheng, Foshan Miss. Yu Xianghong – Sports Vice Director – The Peoples Government of Chancheng, Foshan No formal meetings Greeted by: The Mayor of Medway Cllr. Angela Prodger/ Kathy Wadsworth/ Cllr. Wicks/ Geoff Brown 2007 September 2007 – Foshan Delegation Visit Ms. An Hong – Vice Chairman - Chancheng District People’s Congress Foshan Ms. Li Zhanhua – Deputy Secretary General – Member of Chancheng District Committee Office of Chancheng District People’s Government Mr. Zhang Jianli – Director – Chancheng Bureau of Sports, Foshan Mr. He Zhan – Vice Director – Chancheng Bureau of Economy and Trade Mr. Zhou Haihua – Section Chief – Chancheng Bureau of Foreign Affairs and Overseas Chinese Affairs Mr.
    [Show full text]
  • Foshan Huaxin Packaging Co., Ltd. Annual Report 2018 (Summary)
    Foshan Huaxin Packaging Co., Ltd. Annual Report 2018 (Summary) Stock Code: 200986 Stock Name: Huaxin Packaging-B Announcement No. 2019-012 FOSHAN HUAXIN PACKAGING CO., LTD. ANNUAL REPORT 2018 (SUMMARY) Part I Important Notes This Summary is based on the full text of the 2018 Annual Report of Foshan Huaxin Packaging Co., Ltd. (together with its consolidated subsidiaries, the “Company”, except where the context otherwise requires). In order for a full understanding of the Company’s operating results, financial position and future development plans, investors should carefully read the aforesaid full text, which has been disclosed together with this Summary on the media designated by the China Securities Regulatory Commission (the “CSRC”). Objections raised by any of the directors, supervisors or senior management against any contents in this Report or its summary: Name Office title Objection and explanation of why Statement of objection: Except for the following directors, all the other directors attended in person the Board meeting for the review of this Report and its summary. Reason for not attending the Proxy entrusted to attend the Name Office title meeting in person meeting Zhang Wenjing Independent Director For the reason of work Li Jun Independent auditor’s modified opinion: □ Applicable √ Not applicable Board-approved final cash and/or stock dividend plan for ordinary shareholders: □ Applicable √ Not applicable The Company has no final dividend plan, either in the form of cash or stock. Board-approved final cash and/or stock dividend plan for preferred shareholders: □ Applicable √ Not applicable This Report and its summary have been prepared in both Chinese and English.
    [Show full text]
  • 2019 ANNUAL REPORT Important Notes
    2019 ANNUAL REPORT Important Notes ◎ The Board of Directors, Board of Supervisors, directors, supervisors and senior management of the Company guarantee that the information presented in the Report are true, accurate and complete, and do not contain false records, misrepresentations and major omissions and bear individual and joint legal liabilities. ◎ The 2019 Annual Report was approved on 3 March 2020 by the 11th Meeting of the 7th Board of Directors. Fifteen directors were expected to attend the meeting. Fifteen directors were present at the meeting. Eight supervisors of the Company were present at the meeting. ◎ KPMG Huazhen LLP issued a standard unqualified auditors' report for the Company in accordance with the China Accounting Standards. ◎ The Annual Report is prepared in simplified Chinese, traditional Chinese and in English. The simplified Chinese version shall prevail if the Chinese and English versions do not conform. ◎ Mr. Lu Guofeng, Chairman of the Board of Directors of the Company, Mr. Cheng Jingsong, President of the Bank, Ms. Sun Weiling, Chief Accountant, and Ms. Wei Sanfang, Head of Accounting Department represent that financial reports presented in the Annual Report are true, accurate and complete. ◎ The profit appropriation plan for the reporting period approved at the 11th Meeting of the 7th Board of Directors is to distribute cash dividend totalling RMB 545 million to all shareholders of 2.18 billion capital shares at 31 December 2019 on the basis of RMB 2.5 (including tax) for every 10 shares. ◎ Unless otherwise stated, the accounting and financial data mentioned in the report are consolidated data. ◎ Forward-looking descriptions involved in the report, including future planning and development strategies are not regarded as the Bank’s substantial commitments to its investors.
    [Show full text]
  • China National Accord Medicines Corporation Ltd
    China National Accord Medicines Corporation Ltd. Semi-Annual Report 2020 August 2020 1 Section I. Important Notice, Contents and Interpretation Board of Directors, Supervisory Committee, all directors, supervisors and senior executives of China National Accord Medicines Corporation Ltd. (hereinafter referred to as the Company) hereby confirm that there are no any fictitious statements, misleading statements, or important omissions carried in this report, and shall take all responsibilities, individual and/or joint, for the reality, accuracy and completion of the whole contents. Lin Zhaoxiong, Principal of the Company, Gu Guolin, person in charger of accounting works and Wang Ying, person in charge of accounting organ (accounting principal) hereby confirm that the Financial Report of Semi- Annual Report 2020 is authentic, accurate and complete. Other directors attending the Meeting for annual report deliberation except for the followed: Name of director absent Title for absent director Reasons for absent Attorney Lian Wanyong Director Official business Li Dongjiu The Company plans not to pay cash dividends, bonus and carry out capitalizing of common reserves. 2 Contents Semi-Annual Report 2020..................................................................................................................2 Section I Important Notice, Contents and Interpretation.............................................................. 2 Section II Company Profile and Main Financial Indexes...............................................................5
    [Show full text]
  • 2020 Annual Report
    Contents Company Profile 2 Summary of Financial Data 7 Party Secretary’s Statement 10 President’s Statement 12 Management Discussion and Analysis 13 Changes in Share Capital and Shareholders 55 Directors, Supervisors and Senior Management 66 Corporate Governance Report 77 Report of the Board of Directors 100 Report of the Board of Supervisors 111 Major Events 119 Report on Sannong Financial Services 120 Independent Auditor’s Report 131 Financial Statements and Accompanying Notes 139 Unaudited Supplementary Financial Information 292 Definitions 295 COMPANY PROFILE I. COMPANY PROFILE (I) Official Name 1. Official Chinese Name: 廣州農村商業銀行股份有限公司 (Abbreviated as：“廣州農村商業銀行”) 2. Official English Name: Guangzhou Rural Commercial Bank Co., Ltd. (Abbreviated as “GRCB”) (II) Registered Capital: RMB9,808,268,539.00 (III) Legal representative: Mr. Cai Jian (IV) Authorized Representatives: Mr. Yi Xuefei and Mr. Ngai Wai Fung (V) Joint Company Secretaries: Ms. Zheng Ying and Mr. Ngai Wai Fung (VI) H-Share Listing Stock Exchange: The Stock Exchange of Hong Kong Limited (VII) Stock Name and Code: GRCB (1551.HK) (VIII) Offshore Preference Share Name and Code: GRCB 19USDPREF (4618.HK) (IX) Registered Address: No. 9 Yingri Road, Huangpu District, Guangzhou, PRC (X) Principal Place of Business in Hong Kong: 40th Floor, Dah Sing Financial Centre, No. 248 Queen’s Road East, Wanchai, Hong Kong (XI) Scope of Business: Monetary and financial services (XII) Contact Address: No. 1 Huaxia Road, Pearl River New Town, Tianhe District, Guangzhou, Guangdong Province, PRC
    [Show full text]
  • Hospitals – Guangzhou Responsible Area the Names and Contact Details
    Contact List - Hospitals – Guangzhou Responsible Area The names and contact details of medical services in China appearing below have been compiled by the Department of Foreign Affairs and Trade (DFAT) from publicly-available information. DFAT does not endorse any of the medical services appearing in this list, provides no guarantees as to its currency and does not accept any liability if you choose to engage one of these medical services. Name Address Contact Details Guangzhou Elizabeth Women's No.484 Middle KangWang Road B: + 86 181 2230 0256 Hospital , Liwan District, Guangzhou M: + 86 135 7090 2100 Contact: Michelle Tam City.P .China Fax: +86 20 8132 8199 Email: [email protected] Languages: English, Chinese 广州市荔湾区康王中路484号 Speciality: obstetrics, general pediatrics water birth, Guangzhou gynecology, 4D ultrasound, Guangdong 510010 health check-up China Global Doctor Beijing Alarm Center B: +86 10 5815 1188 Contact: Zou Li 李敏静 M: Fax: +86 8775 9138 Languages: English, Chinese Email: [email protected] Speciality: Global Doctors escort Beijing China Global Doctor 环球医生 D1 2nd Annex, Tianyu Garden B: (86 200 3890-6699 (24 hours) No.136 Linhezhong Rd, Tianhe M: Emergency call: (86) 139-2400- Contact: Global Doctor 环球医生 District 1705 Languages: English, Chinese 广州市天河区林和中路136号天誉花 Fax: (86 20) 3890-6000 Speciality: through our Beijing Email: Alarm Centre, emergency house 园二期D1 [email protected] calls, pre-employment check ups, Tianhe Guangzhou Medical Green Channel, and Guangdong complimentary pick-up service for China patients
    [Show full text]
  • No. Manufacture Name Address Country Certificate of Registration
    รายชื่อโรงงานที่ท าผลติ ภัณฑ์ในตา่ งประเทศที่ไดร้ บั การขึ้นทะเบยี น List of Registered Foreign Manufacturer ขอบข่ายตามมาตรฐานเลขที่ มอก. 934-2558: พัดลมไฟฟ้ากระแสสลบั - คุณลกั ษณะที่ตอ้ งการดา้ นความปลอดภัย TIS 934-2558 : A.C. electric fans: safety requirements No. Manufacture name Address Country Certificate of Date of Date of Expiry Registration No. Registration 1 FOSHAN FUSHIBAO ELECTRICAL CHANCHENG DISTRICT FOSHAN CITY, PEOPLE' S R934-32 5-Jan-2018 4-Jan-2021 APPLIANCE TECNOLOGY CO., LTD. GUANGDONG PROVINCE REPUBLIC OF CHINA 2 SHUNDE DAMIN ENTERPRISE GROUP CO., JIANGCUN IND. LELIU TOWN, SHUNDE, PEOPLE' S R934-33 11-Jan-2018 10-Jan-2021 LTD. OF FOSHAN FOSHAN CITY, GUANGDONG PROVINCE REPUBLIC OF CHINA 3 FOSHAN NANHAI SONGYE ELECTRICAL CAOBIAN 2ND INDUSTRIAL ZONE, DALI, PEOPLE' S R934-34 15-Jan-2018 14-Jan-2021 APPLIANCES CO., LTD. NANHAI DISTRICT, FOSHAN CITY REPUBLIC OF GUANGDONG PROVINCE CHINA 4 CIXI BAILI ELECTRICAL APPLIANCE CO., LTD. WEST INDUSTRIAL ZONE, GUANHAIWEI PEOPLE' S R934-35 5-Feb-2018 4-Feb-2021 TOWN, CIXI CITY, NINGBO REPUBLIC OF CHINA 1/21 รายชื่อโรงงานที่ท าผลติ ภัณฑ์ในตา่ งประเทศที่ไดร้ บั การขึ้นทะเบยี น List of Registered Foreign Manufacturer ขอบข่ายตามมาตรฐานเลขที่ มอก. 934-2558: พัดลมไฟฟ้ากระแสสลบั - คุณลกั ษณะที่ตอ้ งการดา้ นความปลอดภัย TIS 934-2558 : A.C. electric fans: safety requirements No. Manufacture name Address Country Certificate of Date of Date of Expiry Registration No. Registration 5 SHENZHEN KANG MING SHENG BUILD A12, FUKANG INDUSTRIAL PARK, PEOPLE' S R934-36 5-Feb-2018 4-Feb-2021 TECHNOLOGY INDUSTRY INCORPORATED FUMING COMMUNITY, GUANLAN STREET REPUBLIC OF COMPANY LONGHUA, SHENZHEN, GUANGDONG CHINA 6 ZHONGSHAN ASIASTAR ELECTRIC YONGYI INDUSTRIAL AREA, DONGHAI PEOPLE' S R934-37 6-Feb-2018 5-Feb-2021 APPLIANCE CO., LTD.
    [Show full text]
  • Chancheng District Embraces High-Tech in Its Bid to Cut Red Tape
    20 Advertorial Thursday, December 7, 2017 CHINA DAILY CHANCHENG DISTRICT EMBRACES HIGH-TECH IN ITS BID TO CUT RED TAPE Night view of Chancheng district in Foshan. PHOTOS PROVIDED TO CHINA DAILY By LI YOU tions and courses of action to be taken Officials say arrival of the age of information The second highlight of our system [email protected] in response to emergencies ranging is the utilization of information tech- from traffic accidents to street brawls. poses challenges that must be met nology. Big data technology is used Chancheng district, the central dis- In October, the district launched to confirm the unique identity of a trict in the city of Foshan, has become its app on mobile devices — named person,” Liu said. It involved a a model for the successful integration “lingpaotui” — literally means zero In 2016, Chancheng launched a key of information technology and data legwork, which enables its users to project using blockchain technology, transformation of the processing within its administration, access 20 public services at home. trying to build up a digital package officials said. Officials say the arrival of the age for its people. Blockchain utilizes a administration from a That process has helped the dis- of information has brought a lot of secure data structure that enables trict’s public services to reach new challenges that need to be met. identifying and tracking transactions government-oriented levels of transparency and heightened Liu Donghao, Party chief of digitally and sharing the information to a services-oriented efficiency. Chancheng district committee, said across computer networks.
    [Show full text]
  • Ceramic Tableware from China List of CNCA‐Certified Ceramicware
    Ceramic Tableware from China June 15, 2018 List of CNCA‐Certified Ceramicware Factories, FDA Operational List No. 64 740 Firms Eligible for Consideration Under Terms of MOU Firm Name Address City Province Country Mail Code Previous Name XIAOMASHAN OF TAIHU MOUNTAINS, TONGZHA ANHUI HANSHAN MINSHENG PORCELAIN CO., LTD. TOWN HANSHAN COUNTY ANHUI CHINA 238153 ANHUI QINGHUAFANG FINE BONE PORCELAIN CO., LTD HANSHAN ECONOMIC DEVELOPMENT ZONE ANHUI CHINA 238100 HANSHAN CERAMIC CO., LTD., ANHUI PROVINCE NO.21, DONGXING STREET DONGGUAN TOWN HANSHAN COUNTY ANHUI CHINA 238151 WOYANG HUADU FINEPOTTERY CO., LTD FINEOPOTTERY INDUSTRIAL DISTRICT, SOUTH LIUQIAO, WOSHUANG RD WOYANG CITY ANHUI CHINA 233600 THE LISTED NAME OF THIS FACTORY HAS BEEN CHANGED FROM "SIU‐FUNG CERAMICS (CHONGQING SIU‐CERAMICS) CO., LTD." BASED ON NOTIFICATION FROM CNCA CHONGQING CHN&CHN CERAMICS CO., LTD. CHENJIAWAN, LIJIATUO, BANAN DISTRICT CHONGQING CHINA 400054 RECEIVED BY FDA ON FEBRUARY 8, 2002 CHONGQING KINGWAY CERAMICS CO., LTD. CHEN JIA WAN, LI JIA TUO, BANAN DISTRICT, CHONGQING CHINA 400054 BIDA CERAMICS CO.,LTD NO.69,CHENG TIAN SI GE DEHUA COUNTY FUJIAN CHINA 362500 NONE DATIAN COUNTY BAOFENG PORCELAIN PRODUCTS CO., LTD. YONGDE VILLAGE QITAO TOWN DATIAN COUNTY CHINA 366108 FUJIAN CHINA DATIAN YONGDA ART&CRAFT PRODUCTS CO., LTD. NO.156, XIANGSHAN ROAD, JUNXI TOWN, DATIAN COUNTY FUJIAN 366100 DEHUA KAIYUAN PORCELAIN INDUSTRY CO., LTD NO. 63, DONGHUAN ROAD DEHUA TOWN FUJIAN CHINA 362500 THE LISTED ADDRESS OF THIS FACTORY HAS BEEN CHANGED FROM "MAQIUYANG XUNZHONG XUNZHONG TOWN, DEHUA COUNTY" TO THE NEW EAST SIDE, THE SECOND PERIOD, SHIDUN PROJECT ADDRESS LISTED ABOVE BASED ON NOTIFICATION DEHUA HENGHAN ARTS CO., LTD AREA, XUNZHONG TOWN, DEHUA COUNTY FUJIAN CHINA 362500 FROM THE CNCA AUTHORITY IN SEPTEMBER 2014 DEHUA HONGSHENG CERAMICS CO., LTD.
    [Show full text]
  • P12 Directors 40450-10P 56..59
    THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ IN CONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER PAGE OF THIS DOCUMENT. DIRECTORS AND PARTIES INVOLVED IN THE [REDACTED] DIRECTORS Name Residential address Nationality Executive Directors Mr. Liang Juncheng No. 3 Dongli Huayuan 8th Street Chinese (梁俊誠) Fenghua Road, Ronggui Street Shunde District, Foshan City Guangdong Province PRC Mr. Liang Jianheng Hurlington Lodge British (梁建恒) Winkfield Road Ascot, SL5 7LP United Kingdom Mr. Liang Junqian No. 1 Xiangping Street Chinese (梁俊謙) Ronggui Street Shunde District, Foshan City Guangdong Province PRC Mr. Chan Kit Lung Andy G/F Aegean Villa House 1 Chinese (陳杰隆) 5 Silver Cape Road Silverstrand Clear Water Bay Kowloon Hong Kong Independent non-executive Directors Mr. Wong Sui Chi Flat E, 18/F Chinese (黃瑞熾) Block 5 Ocean Shores Tseung Kwan O New Territories, Hong Kong Ms. Hua Min Room 1905, Block 5 Chinese (華敏) (Zhuoyuanjingfengtai No. 5) No. 35 Jihua 3rd Road Chancheng District, Foshan City Guangdong Province PRC – 56 – THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ IN CONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER PAGE OF THIS DOCUMENT. DIRECTORS AND PARTIES INVOLVED IN THE [REDACTED] Name Residential address Nationality Ms. Xiao Ping No. 30 Jiangwan 2nd Road Chinese (肖平) Chancheng District, Foshan City Guangdong Province PRC See ‘‘Directors, Senior Management and Staff’’ for further details of our Directors. PARTIES INVOLVED IN THE [REDACTED] Sponsor Lego Corporate Finance Limited A corporation licensed to carry out Type 6 (advising on corporate finance) regulated activity under the SFO Room 1601, 16/F China Building 29 Queen’sRoadCentral Hong Kong [REDACTED] and [REDACTED] [REDACTED] [REDACTED] – 57 – THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ IN CONJUNCTION WITH THE SECTION HEADED ‘‘WARNING’’ ON THE COVER PAGE OF THIS DOCUMENT.
    [Show full text]
  • Chong Hing Bank Opens Sub-Branch in Dongguan
    企 業 傳 訊 處 Corporate Communications Department Media Release For Immediate Release 8 December 2020 Chong Hing Bank Opens Sub-Branch in Dongguan Chong Hing Bank officially opened its Dongguan Sub-branch on 7 December 2020. This is the Bank’s tenth institution in Mainland China and its eighth Mainland institution in the Guangdong-Hong Kong-Macao Greater Bay Area (the “Greater Bay Area”). The opening of the Dongguan Sub-branch demonstrates the results of the steady development of Chong Hing Bank’s Mainland business and signifies that it has basically achieved the establishment of institutions in the major core cities of the Greater Bay Area, with its network now expanded to seven cities and regions (including Hong Kong and Macau) in the Greater Bay Area. Mr Zhang Zhaoxing, Chairman of Yuexiu Group and Chong Hing Bank; Mr Ye Shanhu, Vice Chairman and General Manager of Yuexiu Group; Mr Lin Zhaoyuan, Chairman of Yuexiu Property; Mr Li Feng, Chief Capital Operations Officer of Yuexiu Group, Chairman of Yuexiu Transport, Director of Chong Hing Bank; Mr Tang Xianqing, Deputy Chief Executive of Chong Hing Bank; Mr Cai Siyang, Deputy Head of Mainland Business Division of Chong Hing Bank and Branch Manager of Guangzhou Branch, together with Mr Luo Huanghao, Deputy Mayor of Dongguan; Mr Liu Jianjun, Director of Dongguan Municipal Financial Bureau; Ms Zhou Xiuwen, Deputy Governor of Dongguan Central Sub-branch of the People’s Bank of China, and leaders of other local government and regulatory authorities, as well as representatives of 27 customers of the Bank, attended the opening ceremony of the Dongguan Sub-branch to witness this important moment.
    [Show full text]